PCMA: Increased Focus on Combating Fraud Integral to Medicare Program Integrity

Share Article

Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt issued the following statement today on a provision in the U.S. Senate’s small business legislation that would require the Department of Health and Human Services (HHS) to work with outside companies to target fraud, waste, and abuse in states across the country.

News Image
Following the passage of health reform, an increased emphasis on overall program integrity and safeguarding taxpayer money is more important than ever, said PCMA President and CEO Mark Merritt.

Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt issued the following statement today on a provision in the U.S. Senate’s small business legislation that would require the Department of Health and Human Services (HHS) to work with outside companies to target fraud, waste, and abuse in states across the country:

“Following the passage of health reform, an increased emphasis on overall program integrity and safeguarding taxpayer money is more important than ever. Focusing on preventing fraud, waste, and abuse is integral to these efforts.

“Along with these initiatives, policymakers must reject policies that inadvertently weaken the ability of public and private payers to detect and prevent fraud, waste, and abuse. It’s far easier to prevent fraud than to engage in ‘pay and chase’ activities after the fact.”

PCMA represents the nation’s pharmacy benefit managers (PBMs), which improve affordability and
quality of care through the use of electronic prescribing (e-prescribing), generic alternatives, mail-service pharmacies, and other innovative tools for 210-plus million Americans.

Follow PCMA on Twitter

Contact: Charles Coté, 202-207-3605

###

Share article on social media or email:

View article via:

Pdf Print